Cellectis Competitors and Similar CompaniesClear all

Cellectis's competitors and similar companies include Polymun and UCB.

	Cellectis Cellectis is a clinical-stage biopharmaceutical company that develops cell and gene therapies.	Polymun Polymun is a company specializing in contract development and manufacturing as well as creating liposomal formats of drugs for contract partners.	UCB UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Founding Date	Founding Date 1999	Founding Date 1992	Founding Date 1928
Type	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech contractor drug development pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Paris, FR HQ New York, US Raleigh, US	Locations Klosterneuburg, AT HQ	Locations Brussels, BE HQ Melbourne, AU Vienna, AT Braine L'alleud, BE Braine L'alleud, BE Leuven, BE São Paulo, BR see more
Employees	Employees 216	Employees 80	Employees 9,052
Valuation ($)	Valuation ($) 189.4 m	Valuation ($) N/A	Valuation ($) 34.3 b
Financial
Revenue (est.)	Revenue (est.) $72.9m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) €7.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods N/A	Cost of goods €1.4b (FY, 2025)
Gross profit	Gross profit $80.2m (FY, 2025)	Gross profit N/A	Gross profit €7.2b (FY, 2025)
Net income	Net income ($67.6m) (FY, 2025)	Net income N/A	Net income €1.6b (FY, 2025)